Tip 2 diabetes mellituslu hastalarda plazma homosistein düzeyinin normal popülasyonla karşılaştırılması
Küçük Resim Yok
Tarih
2012
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Amaç: Preproliferatif ve proliferatif diabetik retinopatili hastalar ile retinopatisi olmayan diabetes mellitus hasta- larının plazma homosistein düzeylerinin normal popülas- yonla karşılaştırılması amaçlanmıştır. Gereç ve yöntem: Tip 2 diabet 23 hastanın plazma ho- mosistein düzeyleri ile benzer yaş grubunda, herhangi bir sistemik hastalığı ve oküler problemi olmayan 25 olgunun plazma homosistein düzeyleri karşılaştırıldı. Homosistein düzeyi yüksek performanslı sıvı kromatografi yöntemi ile ölçüldü. Bulgular: Diabetes mellituslu olgular fundus muayene- lerine göre üç gruba ayrıldı. 8 olguda diabetik retinopati bulgusu olmadığı, 8’inde preproliferatif, 7’sinde proliferatif diabetik retinopati olduğu saptandı. Plazma homosistein düzeyi diabetes mellituslu grupta (ortalama 13,304,03 ?mol/L), kontrol grubuna göre (ortalama 11,713,41 ?mol/L) yüksek olmakla birlikte her iki grup arasında ista- tistiksel olarak anlamlı fark bulunmadı (p0,05). Diabetes mellituslu grup içinde ise diabetik retinopatisi olmayan grupta plazma homosistein düzeyi ortalaması 12,503,73 ?mol/L iken, preproliferatif diabetik retinopati grubunda ortalama 12,902,59 ?mol/L; proliferatif diabetik retinopa- tisi olan grupta ise ortalama 14,645,69 ?mol/L düzeyinde saptandı. Ortalama plazma homosistein düzeyi retinopa- tinin ilerlemesiyle artış göstermekle birlikte bulguların is- tatistiksel analizinde bu artış anlamlı bulunmadı (p0,05). Sonuç: İstatistiksel olarak anlamlı olmamakla birlikte plazma homosistein düzeyinin özellikle retinopati ilerle- dikçe artması plazma homosistein düzeyinin tip 2 diabe- tes mellituslu olguların takibinde kullanılabileceğini ancak daha büyük çalışma gruplarının daha kesin bilgi verebile- ceğini düşündürmektedir.
Objectives: To compare the plasma homocysteine levels between control group and diabetic patients with no dia- betic retinopathy, with preproliferative diabetic retinopa- thy, with proliferative diabetic retinopathy. Materials and methods: Plasma homocysteine levels of 23 diabetic patients were measured and were compared with 25 age-matched controls with no systemic problem and no ocular disease. Plasma homocysteine levels were measured using high-performance liquid chromatogra- phy. Results: Diabetic patients were divided into three groups according to their ophthalmological findings. There were 8 patients with no diabetic retinopathy, 8 patients with preproliferative diabetic retinopathy, 7 patients with pro- liferative diabetic retinopathy. Plasma homocysteine lev- els were higher in diabetic patients (13.30±4.03 μmol/L) compared to the control group (11.71±3.41 μmol/L) but no statistically significant difference was found between the two groups (p>0.05). Plasma homocysteine levels were measured 12.50±3.73 μmol/L in no diabetic retinopathy group, 12.90±2.59 μmol/L in preproliferative diabetic reti- nopathy group, 14.64±5.69 μmol/L in proliferative diabetic retinopathy group. In diabetic group, plasma homocys- teine levels increased with the increase of the severity of retinopathy but not reached statistically significance (p>0.05). Conclusion: Although no statistically significance was found, retinopathy progresses with the increase of plas- ma homocysteine levels. This can be used for the follow- up of the diabetic patients but further evaluation in large groups is needed.
Objectives: To compare the plasma homocysteine levels between control group and diabetic patients with no dia- betic retinopathy, with preproliferative diabetic retinopa- thy, with proliferative diabetic retinopathy. Materials and methods: Plasma homocysteine levels of 23 diabetic patients were measured and were compared with 25 age-matched controls with no systemic problem and no ocular disease. Plasma homocysteine levels were measured using high-performance liquid chromatogra- phy. Results: Diabetic patients were divided into three groups according to their ophthalmological findings. There were 8 patients with no diabetic retinopathy, 8 patients with preproliferative diabetic retinopathy, 7 patients with pro- liferative diabetic retinopathy. Plasma homocysteine lev- els were higher in diabetic patients (13.30±4.03 μmol/L) compared to the control group (11.71±3.41 μmol/L) but no statistically significant difference was found between the two groups (p>0.05). Plasma homocysteine levels were measured 12.50±3.73 μmol/L in no diabetic retinopathy group, 12.90±2.59 μmol/L in preproliferative diabetic reti- nopathy group, 14.64±5.69 μmol/L in proliferative diabetic retinopathy group. In diabetic group, plasma homocys- teine levels increased with the increase of the severity of retinopathy but not reached statistically significance (p>0.05). Conclusion: Although no statistically significance was found, retinopathy progresses with the increase of plas- ma homocysteine levels. This can be used for the follow- up of the diabetic patients but further evaluation in large groups is needed.
Açıklama
Anahtar Kelimeler
Cerrahi
Kaynak
Journal of Clinical and Experimental Investigations
WoS Q Değeri
Scopus Q Değeri
Cilt
3
Sayı
2
